RECRUITINGOBSERVATIONAL
Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
A Prospective, Open Large Cohort Study of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
About This Trial
This is a prospective, open large cohort study to explore biomarkers for detecting early carcinogenesis of IPMN.
Who May Be Eligible (Plain English)
Who May Qualify:
- clinically diagnosed as IPMN;
- without other malignant tumor;
- agree to sign willing to sign a consent form.
Who Should NOT Join This Trial:
- with mental disorders which can affect cognition and cooperation;
- with serious blood diseases or taking drugs that can affect peripheral blood
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* clinically diagnosed as IPMN;
* without other malignant tumor;
* agree to sign informed consent.
Exclusion Criteria:
* with mental disorders which can affect cognition and cooperation;
* with serious blood diseases or taking drugs that can affect peripheral blood
Treatments Being Tested
OTHER
Observation
This is an observational study.
Locations (1)
the First Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China